FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data

FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data

Submitted by admin on August 6, 2023 - 9:34pm
Source: 
BioSpace
News Tags: 
Mesoblast
remestemcel-L
FDA
graft vs host disease
cell therapy
Headline: 
FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data
snippet: 

The FDA has rejected Mesoblast Limited’s application for its investigational immunomodulator remestemcel-L, which it was proposing as a treatment for pediatric steroid-refractory acute graft versus host disease, the company announced Friday.

Do Not Allow Advertisers to Use My Personal information